Nanobiotix Announces the Launch of Curadigm: a New Nanotechnology Platform for Healthcare

Paris, France and Cambridge, Massachusetts, USA, May 28 (Korea Bizwire) – NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the launch of new subsidiary Curadigm, dedicated to redefining the therapeutic balance between bioavailability, toxicity, and efficacy across the pharmaceutical industry. The company will [...]